The Lipidyzer™ Platform: A Revolutionary Tool for Understanding the Role of Lipids in Disease Join us to learn about the key challenges in lipid analysis and how the Lipidyzer platform can help you overcome them.
The Bru-seq Technology Platform for Nascent RNA analysis Mats Ljungman, Professor, University of Michigan will present a set of novel techniques to analyze many aspects of gene expression based on the capturing of nascent RNA.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
New Metabolomics Biomarker for Heart Failure Philipp Schatz, Metanomics Health GmbH, speaking at Diagnostics & Biomarkers 2015.
LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
Recent Foodomic Developments to Investigate the Bioactivity of Dietary Ingredients Alejandro Cifuentes, Institute of Food Science Research, speaking at Food Analysis Congress.
Diagnosis of Disorders Affecting Steroid Synthesis and Metabolism by Mass Spectrometry Josep Marcos del Aguila, IMIM, speaking at Clinical Applications of Mass Spectrometry 2014.
Combining Computational Biology and High Content Imaging Approaches for Understanding DNA Damage and Repair Thierry Dorval, AstraZeneca, speaking at High Content Analysis 2014
Insights from Metabolomics in Compartmented Cells Ralf Takors, University of Stuttgart, speaking at Advances in Cellular Assays & Cell Culture 2014
Advances in Volatile Analyses for Disease Diagnosis Norman Ratcliffe, University of the West of England, speaking at Advances in Biodetection & Biosensors 2014.